| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 6.08e-06 | 133 | 68 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 8.17e-06 | 140 | 68 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC38A1 SLC12A6 KCNQ4 PIEZO1 TRPM2 OTOP1 SLC5A9 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 1.38e-05 | 664 | 68 | 11 | GO:0008324 |
| GeneOntologyMolecularFunction | transporter activity | SLC38A1 SLC12A6 TMEM184A SLC16A4 KCNQ4 PIEZO1 TRPM2 SLC22A11 OTOP1 SLC5A9 MCL1 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 2.24e-05 | 1289 | 68 | 15 | GO:0005215 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC38A1 SLC12A6 KCNQ4 TRPM2 SLC5A9 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 2.72e-05 | 465 | 68 | 9 | GO:0046873 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 2.97e-05 | 18 | 68 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC38A1 SLC12A6 SLC16A4 KCNQ4 PIEZO1 TRPM2 SLC22A11 OTOP1 SLC5A9 MCL1 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 3.58e-05 | 1180 | 68 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | CCR2 NPY1R DRD3 CYSLTR1 OR4A47 MC2R GPR84 CCR3 TACR3 GABBR2 TM2D1 PTH1R | 3.89e-05 | 884 | 68 | 12 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | CCR2 NPY1R DRD3 CYSLTR1 OR4A47 UNC5C MC2R GPR84 CCR3 TACR3 GABBR2 TM2D1 IL18RAP UNC5D PTH1R | 3.94e-05 | 1353 | 68 | 15 | GO:0004888 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC38A1 SLC12A6 KCNQ4 TRPM2 SLC22A11 OTOP1 SLC5A9 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 4.67e-05 | 758 | 68 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC38A1 SLC12A6 KCNQ4 TRPM2 OTOP1 SLC5A9 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 4.89e-05 | 627 | 68 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | channel activity | 6.96e-05 | 525 | 68 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC38A1 SLC12A6 KCNQ4 PIEZO1 TRPM2 OTOP1 SLC5A9 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 7.01e-05 | 793 | 68 | 11 | GO:0015075 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 7.06e-05 | 526 | 68 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 1.14e-04 | 5 | 68 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.59e-04 | 31 | 68 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | symporter activity | 1.59e-04 | 150 | 68 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.64e-04 | 343 | 68 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | netrin receptor activity | 1.70e-04 | 6 | 68 | 2 | GO:0005042 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.92e-04 | 33 | 68 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic cation channel activity | 2.37e-04 | 7 | 68 | 2 | GO:0140135 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 2.37e-04 | 7 | 68 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.93e-04 | 171 | 68 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 4.53e-04 | 44 | 68 | 3 | GO:0046915 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 5.11e-04 | 296 | 68 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | iron ion transmembrane transporter activity | 6.16e-04 | 11 | 68 | 2 | GO:0005381 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 7.28e-04 | 119 | 68 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 7.83e-04 | 53 | 68 | 3 | GO:0008188 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 9.38e-04 | 459 | 68 | 7 | GO:0005216 | |
| GeneOntologyMolecularFunction | gated channel activity | 9.59e-04 | 334 | 68 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | protein antigen binding | 1.33e-03 | 16 | 68 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 1.50e-03 | 17 | 68 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 1.69e-03 | 18 | 68 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.09e-03 | 20 | 68 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.54e-03 | 167 | 68 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.67e-03 | 81 | 68 | 3 | GO:0015370 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 2.76e-03 | 23 | 68 | 2 | GO:0016493 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 3.00e-03 | 24 | 68 | 2 | GO:0019957 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 3.26e-03 | 25 | 68 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 3.26e-03 | 25 | 68 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 3.52e-03 | 26 | 68 | 2 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 3.52e-03 | 26 | 68 | 2 | GO:0004950 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 3.80e-03 | 27 | 68 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 4.37e-03 | 29 | 68 | 2 | GO:0051119 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 4.43e-03 | 97 | 68 | 3 | GO:0004896 | |
| GeneOntologyMolecularFunction | chemokine binding | 5.64e-03 | 33 | 68 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 5.65e-03 | 477 | 68 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 9.01e-03 | 42 | 68 | 2 | GO:0015144 | |
| GeneOntologyMolecularFunction | potassium channel activity | 9.52e-03 | 128 | 68 | 3 | GO:0005267 | |
| GeneOntologyMolecularFunction | calcium channel activity | 9.73e-03 | 129 | 68 | 3 | GO:0005262 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC38A1 CCR2 SLC12A6 IBTK DRD3 KCNQ4 CYSLTR1 PIEZO1 CYP27B1 TRPM2 SLC22A11 OTOP1 SLC5A9 MCOLN1 KCNK4 CNTN1 MCOLN2 SLC5A3 | 1.47e-07 | 1374 | 65 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC38A1 SLC12A6 IBTK DRD3 KCNQ4 CYSLTR1 PIEZO1 CYP27B1 TRPM2 OTOP1 SLC5A9 MCOLN1 KCNK4 CNTN1 MCOLN2 SLC5A3 | 4.14e-07 | 1157 | 65 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC38A1 SLC12A6 IBTK DRD3 KCNQ4 CYSLTR1 CYP27B1 TRPM2 SLC5A9 MCOLN1 KCNK4 CNTN1 MCOLN2 SLC5A3 | 2.18e-06 | 1000 | 65 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | netrin-activated signaling pathway | 2.48e-06 | 9 | 65 | 3 | GO:0038007 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC38A1 SLC12A6 IBTK DRD3 KCNQ4 PIEZO1 TRPM2 OTOP1 SLC5A9 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 6.25e-06 | 942 | 65 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC38A1 CCR2 SLC12A6 IBTK DRD3 KCNQ4 PIEZO1 TRPM2 OTOP1 SLC5A9 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 7.68e-06 | 1115 | 65 | 14 | GO:0034220 |
| GeneOntologyBiologicalProcess | negative regulation of adenylate cyclase activity | 2.36e-05 | 18 | 65 | 3 | GO:0007194 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC38A1 SLC12A6 IBTK DRD3 KCNQ4 TRPM2 OTOP1 SLC5A9 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 2.68e-05 | 922 | 65 | 12 | GO:0098662 |
| GeneOntologyBiologicalProcess | negative regulation of cyclase activity | 2.79e-05 | 19 | 65 | 3 | GO:0031280 | |
| GeneOntologyBiologicalProcess | calcium ion homeostasis | 2.94e-05 | 389 | 65 | 8 | GO:0055074 | |
| GeneOntologyBiologicalProcess | negative regulation of lyase activity | 4.41e-05 | 22 | 65 | 3 | GO:0051350 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC38A1 SLC12A6 IBTK DRD3 KCNQ4 TRPM2 OTOP1 SLC5A9 MCOLN1 KCNK4 MCOLN2 SLC5A3 | 6.93e-05 | 1017 | 65 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 9.72e-05 | 5 | 65 | 2 | GO:0051919 | |
| GeneOntologyBiologicalProcess | cellular response to temperature stimulus | 9.72e-05 | 5 | 65 | 2 | GO:0071502 | |
| GeneOntologyBiologicalProcess | intracellular calcium ion homeostasis | 1.34e-04 | 359 | 65 | 7 | GO:0006874 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 1.38e-04 | 622 | 65 | 9 | GO:0098771 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF, modulating synaptic transmission | 2.03e-04 | 7 | 65 | 2 | GO:0099183 | |
| GeneOntologyBiologicalProcess | type 2 mitophagy | 2.03e-04 | 7 | 65 | 2 | GO:0061734 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | CCR2 SLC12A6 IBTK NPY1R DRD3 LPA TRPM2 MCL1 PLG MCOLN1 PTH1R | 2.25e-04 | 981 | 65 | 11 | GO:0019725 |
| GeneOntologyBiologicalProcess | sodium ion transport | 2.27e-04 | 275 | 65 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling by BDNF | 2.70e-04 | 8 | 65 | 2 | GO:0099191 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 2.81e-04 | 286 | 65 | 6 | GO:0007188 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 3.49e-04 | 705 | 65 | 9 | GO:0055080 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 3.95e-04 | 717 | 65 | 9 | GO:0050801 | |
| GeneOntologyBiologicalProcess | host-mediated regulation of intestinal microbiota composition | 4.33e-04 | 10 | 65 | 2 | GO:0048874 | |
| GeneOntologyBiologicalProcess | protein targeting to vacuole | 4.96e-04 | 49 | 65 | 3 | GO:0006623 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 5.02e-04 | 208 | 65 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 6.27e-04 | 931 | 65 | 10 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 6.27e-04 | 931 | 65 | 10 | GO:0007268 | |
| GeneOntologyBiologicalProcess | neuropeptide signaling pathway | 6.35e-04 | 124 | 65 | 4 | GO:0007218 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 6.70e-04 | 939 | 65 | 10 | GO:0099537 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 8.56e-04 | 59 | 65 | 3 | GO:0045761 | |
| GeneOntologyBiologicalProcess | negative regulation of fibrinolysis | 8.68e-04 | 14 | 65 | 2 | GO:0051918 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with symbiont | 8.72e-04 | 135 | 65 | 4 | GO:0051702 | |
| GeneOntologyBiologicalProcess | axon development | 8.92e-04 | 642 | 65 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 9.02e-04 | 976 | 65 | 10 | GO:0099536 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 9.44e-04 | 61 | 65 | 3 | GO:0007187 | |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | 9.66e-04 | 650 | 65 | 8 | GO:0061919 | |
| GeneOntologyBiologicalProcess | autophagy | 9.66e-04 | 650 | 65 | 8 | GO:0006914 | |
| GeneOntologyCellularComponent | basal part of cell | 2.25e-04 | 378 | 68 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.74e-04 | 519 | 68 | 8 | GO:0009897 | |
| MousePheno | abnormal mammary gland connective tissue morphology | 1.81e-05 | 2 | 60 | 2 | MP:0009507 | |
| MousePheno | ectropion | 1.81e-05 | 2 | 60 | 2 | MP:0006164 | |
| MousePheno | esophageal ulcer | 1.81e-05 | 2 | 60 | 2 | MP:0004547 | |
| MousePheno | duodenal ulcer | 1.81e-05 | 2 | 60 | 2 | MP:0003273 | |
| MousePheno | perianal ulcer | 1.81e-05 | 2 | 60 | 2 | MP:0005035 | |
| MousePheno | abnormal cell migration | 4.81e-05 | 501 | 60 | 10 | MP:0003091 | |
| MousePheno | abnormal behavioral response to xenobiotic | 4.90e-05 | 309 | 60 | 8 | MP:0009745 | |
| MousePheno | ectopic neuron | 5.18e-05 | 48 | 60 | 4 | MP:0011723 | |
| MousePheno | absent cornea epithelium | 5.42e-05 | 3 | 60 | 2 | MP:0020856 | |
| MousePheno | ectopic cortical neuron | 5.42e-05 | 3 | 60 | 2 | MP:0011724 | |
| MousePheno | choroidal neovascularization | 6.94e-05 | 19 | 60 | 3 | MP:0005546 | |
| MousePheno | abnormal posture | 7.75e-05 | 243 | 60 | 7 | MP:0001504 | |
| MousePheno | abnormal hippocampus morphology | 7.95e-05 | 331 | 60 | 8 | MP:0000807 | |
| MousePheno | abnormal temporal lobe morphology | 9.01e-05 | 337 | 60 | 8 | MP:0000801 | |
| MousePheno | increased circulating fibrinogen level | 1.08e-04 | 4 | 60 | 2 | MP:0012331 | |
| MousePheno | proctitis | 1.08e-04 | 4 | 60 | 2 | MP:0003305 | |
| MousePheno | abnormal macrophage physiology | 1.20e-04 | 451 | 60 | 9 | MP:0002451 | |
| MousePheno | abnormal neuronal migration | 1.26e-04 | 114 | 60 | 5 | MP:0006009 | |
| MousePheno | abnormal nervous system tract morphology | 1.54e-04 | 189 | 60 | 6 | MP:0000778 | |
| MousePheno | abnormal limbic system morphology | 1.99e-04 | 378 | 60 | 8 | MP:0004166 | |
| MousePheno | abnormal choroid vasculature morphology | 2.04e-04 | 27 | 60 | 3 | MP:0006237 | |
| MousePheno | decreased circulating interleukin level | 2.09e-04 | 127 | 60 | 5 | MP:0014498 | |
| MousePheno | decreased interleukin level | 2.17e-04 | 128 | 60 | 5 | MP:0014438 | |
| MousePheno | abnormal locomotor coordination | CCR2 SLC12A6 CLDN11 DSCAM NFIX ACAN AP5Z1 UNC5C OTOP1 MCOLN1 CNTN1 | 2.29e-04 | 726 | 60 | 11 | MP:0003312 |
| MousePheno | intervertebral disk degeneration | 2.69e-04 | 6 | 60 | 2 | MP:0004684 | |
| MousePheno | increased neocortex size | 2.69e-04 | 6 | 60 | 2 | MP:0020067 | |
| MousePheno | gastric ulcer | 2.69e-04 | 6 | 60 | 2 | MP:0003282 | |
| MousePheno | abnormal inner ear morphology | 3.03e-04 | 303 | 60 | 7 | MP:0000026 | |
| MousePheno | abnormal stomach mucosa morphology | 3.28e-04 | 77 | 60 | 4 | MP:0010792 | |
| MousePheno | abnormal somatic nervous system morphology | CCR2 SLC12A6 CLDN11 NPY1R DSCAM KCNQ4 ACAN UNC5C ESPNL OTOP1 EML1 MCOLN1 SLC5A3 | 3.32e-04 | 1025 | 60 | 13 | MP:0002752 |
| MousePheno | abnormal gait | 3.47e-04 | 520 | 60 | 9 | MP:0001406 | |
| MousePheno | delayed eyelid opening | 3.74e-04 | 33 | 60 | 3 | MP:0001290 | |
| MousePheno | decreased circulating cytokine level | 3.75e-04 | 144 | 60 | 5 | MP:0014494 | |
| MousePheno | increased acute phase protein level | 3.75e-04 | 7 | 60 | 2 | MP:0014499 | |
| MousePheno | venoocclusion | 3.75e-04 | 7 | 60 | 2 | MP:0006137 | |
| MousePheno | abnormal conjunctival epithelium morphology | 3.75e-04 | 7 | 60 | 2 | MP:0004481 | |
| MousePheno | peptic ulcer | 3.75e-04 | 7 | 60 | 2 | MP:0003301 | |
| MousePheno | abnormal stomach wall morphology | 3.80e-04 | 80 | 60 | 4 | MP:0010783 | |
| MousePheno | abnormal alcohol consumption | 4.46e-04 | 35 | 60 | 3 | MP:0001425 | |
| MousePheno | enlarged lateral ventricles | 4.58e-04 | 84 | 60 | 4 | MP:0008535 | |
| MousePheno | abnormal circulating fibrinogen level | 4.99e-04 | 8 | 60 | 2 | MP:0010213 | |
| MousePheno | decreased keratinocyte migration | 4.99e-04 | 8 | 60 | 2 | MP:0012194 | |
| MousePheno | abnormal cochlear outer hair cell morphology | 5.90e-04 | 159 | 60 | 5 | MP:0004399 | |
| MousePheno | decreased circulating interleukin-12 level | 6.40e-04 | 9 | 60 | 2 | MP:0008618 | |
| MousePheno | muscle hypertonia | 6.40e-04 | 9 | 60 | 2 | MP:0004143 | |
| MousePheno | abnormal avoidance learning behavior | 7.01e-04 | 94 | 60 | 4 | MP:0001462 | |
| MousePheno | impaired avoidance learning behavior | 7.66e-04 | 42 | 60 | 3 | MP:0012312 | |
| MousePheno | decreased susceptibility to induced choroidal neovascularization | 7.97e-04 | 10 | 60 | 2 | MP:0003434 | |
| MousePheno | abnormal kidney thrombosis | 7.97e-04 | 10 | 60 | 2 | MP:0011507 | |
| MousePheno | abnormal ear morphology | 8.48e-04 | 470 | 60 | 8 | MP:0002102 | |
| MousePheno | abnormal membranous labyrinth morphology | 8.78e-04 | 262 | 60 | 6 | MP:0000035 | |
| MousePheno | abnormal cerebral hemisphere morphology | 9.60e-04 | 599 | 60 | 9 | MP:0008540 | |
| MousePheno | abnormal cortical intermediate zone morphology | 9.72e-04 | 11 | 60 | 2 | MP:0008457 | |
| MousePheno | abnormal keratinocyte migration | 9.72e-04 | 11 | 60 | 2 | MP:0012192 | |
| MousePheno | increased locomotor activity | 9.81e-04 | 178 | 60 | 5 | MP:0031391 | |
| MousePheno | abnormal neuron physiology | 1.02e-03 | 604 | 60 | 9 | MP:0004811 | |
| MousePheno | abnormal immune serum protein physiology | CCR2 ZDHHC11B NPY1R LRRC19 CARD9 LPA TRPM2 HLA-E GPR84 CCR3 PLG IL18RAP MCOLN2 | 1.12e-03 | 1165 | 60 | 13 | MP:0002723 |
| MousePheno | abnormal neuron differentiation | 1.13e-03 | 275 | 60 | 6 | MP:0009937 | |
| MousePheno | abnormal hippocampus region morphology | 1.35e-03 | 51 | 60 | 3 | MP:0008262 | |
| MousePheno | abnormal cingulate cortex morphology | 1.37e-03 | 13 | 60 | 2 | MP:0020749 | |
| MousePheno | abnormal conjunctiva morphology | 1.37e-03 | 13 | 60 | 2 | MP:0001310 | |
| MousePheno | abnormal Purkinje cell axon morphology | 1.37e-03 | 13 | 60 | 2 | MP:0014329 | |
| MousePheno | abnormal anus morphology | 1.37e-03 | 13 | 60 | 2 | MP:0005034 | |
| MousePheno | abnormal optic choroid morphology | 1.43e-03 | 52 | 60 | 3 | MP:0005098 | |
| MousePheno | abnormal neocortex size | 1.59e-03 | 14 | 60 | 2 | MP:0020066 | |
| MousePheno | abnormal Ammon gyrus morphology | 1.68e-03 | 55 | 60 | 3 | MP:0000815 | |
| MousePheno | abnormal cochlear hair cell morphology | 1.72e-03 | 202 | 60 | 5 | MP:0002622 | |
| MousePheno | increased alcohol consumption | 1.84e-03 | 15 | 60 | 2 | MP:0003545 | |
| MousePheno | abnormal cochlear sensory epithelium morphology | 1.91e-03 | 207 | 60 | 5 | MP:0003308 | |
| Domain | UPA | 1.18e-04 | 5 | 65 | 2 | IPR033772 | |
| Domain | UPA | 1.18e-04 | 5 | 65 | 2 | PF17217 | |
| Domain | HELP | 1.77e-04 | 6 | 65 | 2 | PF03451 | |
| Domain | HELP | 1.77e-04 | 6 | 65 | 2 | IPR005108 | |
| Domain | Na/solute_symporter_CS | 3.29e-04 | 8 | 65 | 2 | IPR018212 | |
| Domain | ZU5 | 4.23e-04 | 9 | 65 | 2 | SM00218 | |
| Domain | GPCR_Rhodpsn_7TM | 4.95e-04 | 670 | 65 | 9 | IPR017452 | |
| Domain | Ig_I-set | 5.21e-04 | 190 | 65 | 5 | IPR013098 | |
| Domain | I-set | 5.21e-04 | 190 | 65 | 5 | PF07679 | |
| Domain | ZU5 | 5.27e-04 | 10 | 65 | 2 | PS51145 | |
| Domain | 7tm_1 | 5.33e-04 | 677 | 65 | 9 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 5.80e-04 | 685 | 65 | 9 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 6.18e-04 | 691 | 65 | 9 | PS50262 | |
| Domain | GPCR_Rhodpsn | 6.24e-04 | 692 | 65 | 9 | IPR000276 | |
| Domain | NA_SOLUT_SYMP_1 | 6.43e-04 | 11 | 65 | 2 | PS00456 | |
| Domain | PKD_channel | 6.43e-04 | 11 | 65 | 2 | PF08016 | |
| Domain | PKD1_2_channel | 6.43e-04 | 11 | 65 | 2 | IPR013122 | |
| Domain | Ion_trans_dom | 6.69e-04 | 114 | 65 | 4 | IPR005821 | |
| Domain | Ion_trans | 6.69e-04 | 114 | 65 | 4 | PF00520 | |
| Domain | NA_SOLUT_SYMP_2 | 7.70e-04 | 12 | 65 | 2 | PS00457 | |
| Domain | SSF | 7.70e-04 | 12 | 65 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 7.70e-04 | 12 | 65 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 7.70e-04 | 12 | 65 | 2 | PS50283 | |
| Domain | ZU5 | 7.70e-04 | 12 | 65 | 2 | PF00791 | |
| Domain | ZU5_dom | 7.70e-04 | 12 | 65 | 2 | IPR000906 | |
| Domain | IGc2 | 1.35e-03 | 235 | 65 | 5 | SM00408 | |
| Domain | Ig_sub2 | 1.35e-03 | 235 | 65 | 5 | IPR003598 | |
| Domain | Chemokine_rcpt | 1.39e-03 | 16 | 65 | 2 | IPR000355 | |
| Domain | IG_LIKE | 1.55e-03 | 491 | 65 | 7 | PS50835 | |
| Domain | Kringle | 1.57e-03 | 17 | 65 | 2 | IPR000001 | |
| Domain | HEAT_type_2 | 1.57e-03 | 17 | 65 | 2 | IPR021133 | |
| Domain | Kringle_CS | 1.57e-03 | 17 | 65 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 1.57e-03 | 17 | 65 | 2 | PS50070 | |
| Domain | Kringle | 1.57e-03 | 17 | 65 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 1.57e-03 | 17 | 65 | 2 | PS00021 | |
| Domain | KR | 1.57e-03 | 17 | 65 | 2 | SM00130 | |
| Domain | Ig-like_dom | 1.78e-03 | 503 | 65 | 7 | IPR007110 | |
| Domain | - | 2.05e-03 | 663 | 65 | 8 | 2.60.40.10 | |
| Domain | Ig-like_fold | 3.02e-03 | 706 | 65 | 8 | IPR013783 | |
| Domain | IG | 3.41e-03 | 421 | 65 | 6 | SM00409 | |
| Domain | Ig_sub | 3.41e-03 | 421 | 65 | 6 | IPR003599 | |
| Domain | DEATH | 3.96e-03 | 27 | 65 | 2 | SM00005 | |
| Domain | - | 4.18e-03 | 93 | 65 | 3 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 4.97e-03 | 99 | 65 | 3 | IPR011029 | |
| Domain | Kringle-like | 5.53e-03 | 32 | 65 | 2 | IPR013806 | |
| Domain | Death | 5.87e-03 | 33 | 65 | 2 | PF00531 | |
| Domain | 7TM_GPCR_Srsx | 7.00e-03 | 112 | 65 | 3 | SM01381 | |
| Domain | - | 7.47e-03 | 222 | 65 | 4 | 1.25.10.10 | |
| Domain | Death_domain | 7.73e-03 | 38 | 65 | 2 | IPR000488 | |
| Domain | DEATH_DOMAIN | 7.73e-03 | 38 | 65 | 2 | PS50017 | |
| Pathway | WP_GPCRS_NONODORANT | 6.71e-07 | 266 | 54 | 9 | MM15843 | |
| Pathway | WP_GPCRS_PEPTIDE | 6.84e-06 | 70 | 54 | 5 | MM15959 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 8.36e-06 | 272 | 54 | 8 | M13380 | |
| Pathway | WP_PEPTIDE_GPCRS | 9.61e-06 | 75 | 54 | 5 | M39696 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 2.33e-05 | 44 | 54 | 4 | M875 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CCR2 NPY1R DRD3 TRIO CYSLTR1 MC2R GPR84 CCR3 TACR3 GABBR2 PTH1R | 5.81e-05 | 702 | 54 | 11 | M746 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 5.88e-05 | 463 | 54 | 9 | M507 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 7.43e-05 | 186 | 54 | 6 | MM15994 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 1.47e-04 | 646 | 54 | 10 | MM14962 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.63e-04 | 28 | 54 | 3 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.63e-04 | 28 | 54 | 3 | M27241 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.13e-04 | 430 | 54 | 8 | MM15160 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.49e-04 | 330 | 54 | 7 | M18334 | |
| Pathway | REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS | 3.97e-04 | 8 | 54 | 2 | M27328 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.57e-04 | 260 | 54 | 6 | M39397 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 9.19e-04 | 197 | 54 | 5 | M12289 | |
| Pathway | BIOCARTA_FIBRINOLYSIS_PATHWAY | 9.27e-04 | 12 | 54 | 2 | MM1398 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 9.40e-04 | 114 | 54 | 4 | MM14571 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.27e-03 | 14 | 54 | 2 | MM1458 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.46e-03 | 15 | 54 | 2 | M27161 | |
| Pathway | REACTOME_DISSOLUTION_OF_FIBRIN_CLOT | 1.46e-03 | 15 | 54 | 2 | MM15450 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 1.46e-03 | 15 | 54 | 2 | MM14965 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 1.65e-03 | 333 | 54 | 6 | MM14963 | |
| Pathway | WP_BDNF_PATHWAY | 1.67e-03 | 16 | 54 | 2 | MM15816 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC38A1 SLC12A6 LPA TRPM2 SLC22A11 SLC5A9 MCOLN1 MCOLN2 SLC5A3 | 1.76e-03 | 736 | 54 | 9 | M27287 |
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 25165151 | ||
| Pubmed | CCL2/MCP-1 signaling drives extracellular matrix turnover by diverse macrophage subsets. | 1.42e-07 | 6 | 68 | 3 | 33543002 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 19693089 | ||
| Pubmed | A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo. | 1.17e-06 | 11 | 68 | 3 | 26647393 | |
| Pubmed | 1.44e-06 | 179 | 68 | 6 | 18577758 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 31690812 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30254165 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 38328826 | ||
| Pubmed | Reduced transplant arteriosclerosis in plasminogen-deficient mice. | 3.77e-06 | 2 | 68 | 2 | 9819364 | |
| Pubmed | Persistent corneal haze after excimer laser photokeratectomy in plasminogen-deficient mice. | 3.77e-06 | 2 | 68 | 2 | 10634603 | |
| Pubmed | Thrombomodulin functions as a plasminogen receptor to modulate angiogenesis. | 3.77e-06 | 2 | 68 | 2 | 23943648 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12083480 | ||
| Pubmed | Polymorphonuclear leukocyte phagocytic function increases in plasminogen knockout mice. | 3.77e-06 | 2 | 68 | 2 | 18420257 | |
| Pubmed | Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. | 3.77e-06 | 2 | 68 | 2 | 7705657 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23041318 | ||
| Pubmed | Plasminogen alleles influence susceptibility to invasive aspergillosis. | 3.77e-06 | 2 | 68 | 2 | 18566672 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19752236 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 6216475 | ||
| Pubmed | The generation and characterization of mice expressing a plasmin-inactivating active site mutation. | 3.77e-06 | 2 | 68 | 2 | 20653841 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 18439550 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12428098 | ||
| Pubmed | Tissue-type plasminogen activator is a neuroprotectant in the mouse hippocampus. | 3.77e-06 | 2 | 68 | 2 | 20440070 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24732409 | ||
| Pubmed | A central role for plasminogen in the inflammatory response to biomaterials. | 3.77e-06 | 2 | 68 | 2 | 15456492 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24876560 | ||
| Pubmed | Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice. | 3.77e-06 | 2 | 68 | 2 | 24574269 | |
| Pubmed | Spontaneous development of otitis media in plasminogen-deficient mice. | 3.77e-06 | 2 | 68 | 2 | 16956791 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 25409527 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 1543918 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8704243 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17267741 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23702659 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 29990619 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17293777 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23456978 | ||
| Pubmed | Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction. | 3.77e-06 | 2 | 68 | 2 | 10854210 | |
| Pubmed | Gender affects skin wound healing in plasminogen deficient mice. | 3.77e-06 | 2 | 68 | 2 | 23527289 | |
| Pubmed | Dengue virus-induced autoantibodies bind to plasminogen and enhance its activation. | 3.77e-06 | 2 | 68 | 2 | 22079981 | |
| Pubmed | Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. | 3.77e-06 | 2 | 68 | 2 | 9490683 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16481742 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 18983515 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34378815 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11848464 | ||
| Pubmed | Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. | 3.77e-06 | 2 | 68 | 2 | 7586361 | |
| Pubmed | Plasminogen/plasmin modulates bone metabolism by regulating the osteoblast and osteoclast function. | 3.77e-06 | 2 | 68 | 2 | 21239499 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10642175 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12225871 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9770530 | ||
| Pubmed | The tissue-specific expression of TRPML2 (MCOLN-2) gene is influenced by the presence of TRPML1. | 3.77e-06 | 2 | 68 | 2 | 19763610 | |
| Pubmed | Plasminogen activation is required for the development of radiation-induced dermatitis. | 3.77e-06 | 2 | 68 | 2 | 30323258 | |
| Pubmed | Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. | 3.77e-06 | 2 | 68 | 2 | 37971174 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9884337 | ||
| Pubmed | Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. | 3.77e-06 | 2 | 68 | 2 | 26473342 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10816371 | ||
| Pubmed | Plasminogen is a critical regulator of cutaneous wound healing. | 3.77e-06 | 2 | 68 | 2 | 26791370 | |
| Pubmed | The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. | 3.77e-06 | 2 | 68 | 2 | 18794901 | |
| Pubmed | Selection of mutant µplasmin for amyloid-β cleavage in vivo. | 3.77e-06 | 2 | 68 | 2 | 32694536 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 7525077 | ||
| Pubmed | Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models. | 3.77e-06 | 2 | 68 | 2 | 16052596 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17122079 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 16103174 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21300353 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15737740 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11306011 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12149246 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 22056679 | ||
| Pubmed | Protective effects of plasmin(ogen) in a mouse model of Staphylococcus aureus-induced arthritis. | 3.77e-06 | 2 | 68 | 2 | 18311818 | |
| Pubmed | Localization of plasminogen in mouse hippocampus, cerebral cortex, and hypothalamus. | 3.77e-06 | 2 | 68 | 2 | 21190118 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 18039665 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9671388 | ||
| Pubmed | A physiological function for apolipoprotein(a): a natural regulator of the inflammatory response. | 3.77e-06 | 2 | 68 | 2 | 18997104 | |
| Pubmed | Growth and behavioral development in plasminogen gene-targeted mice. | 3.77e-06 | 2 | 68 | 2 | 10885855 | |
| Pubmed | Association of IL18RAP and CCR3 with coeliac disease in the Spanish population. | 3.77e-06 | 2 | 68 | 2 | 19542083 | |
| Pubmed | Cellular density regulation of plasminogen gene expression in mouse hepatocytes. | 3.77e-06 | 2 | 68 | 2 | 12559391 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 27319402 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 26289103 | ||
| Pubmed | Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. | 3.77e-06 | 2 | 68 | 2 | 15333838 | |
| Pubmed | Apo(a) promotes thrombosis in a vascular injury model by a mechanism independent of plasminogen. | 3.77e-06 | 2 | 68 | 2 | 16150044 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 11916082 | ||
| Pubmed | Unaltered prion protein cleavage in plasminogen-deficient mice. | 3.77e-06 | 2 | 68 | 2 | 16543819 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 34423816 | ||
| Pubmed | Delayed invasion of the kidney and brain by Borrelia crocidurae in plasminogen-deficient mice. | 3.77e-06 | 2 | 68 | 2 | 11500461 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12167431 | ||
| Pubmed | Impaired wound healing in mice with a disrupted plasminogen gene. | 3.77e-06 | 2 | 68 | 2 | 8612226 | |
| Pubmed | Role of plasminogen activation in neuronal organization and survival. | 3.77e-06 | 2 | 68 | 2 | 19683575 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 10537128 | ||
| Pubmed | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis. | 3.77e-06 | 2 | 68 | 2 | 23555246 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 18685433 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 31462325 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 36075514 | ||
| Pubmed | Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. | 3.77e-06 | 2 | 68 | 2 | 9242524 | |
| Pubmed | 3.93e-06 | 16 | 68 | 3 | 8406442 | ||
| Pubmed | 1.07e-05 | 22 | 68 | 3 | 22726835 | ||
| Pubmed | 1.07e-05 | 22 | 68 | 3 | 25107907 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16818777 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 19273908 | ||
| Pubmed | Lactational competence and involution of the mouse mammary gland require plasminogen. | 1.13e-05 | 3 | 68 | 2 | 11003846 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 28320709 | ||
| Pubmed | Plasminogen directs the pleiotropic effects of uPA in liver injury and repair. | 1.13e-05 | 3 | 68 | 2 | 12431907 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 16413499 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q26 | 2.56e-04 | 16 | 68 | 2 | chr6q26 | |
| Cytoband | 6q26 | 3.26e-04 | 18 | 68 | 2 | 6q26 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 1.27e-03 | 316 | 68 | 4 | chr3p21 | |
| GeneFamily | Transient receptor potential cation channels | 6.59e-05 | 28 | 51 | 3 | 249 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 8.88e-05 | 161 | 51 | 5 | 593 | |
| GeneFamily | CD molecules|C-C motif chemokine receptors | 3.46e-04 | 10 | 51 | 2 | 1091 | |
| GeneFamily | Solute carriers | 8.22e-04 | 395 | 51 | 6 | 752 | |
| GeneFamily | WD repeat domain containing | 6.32e-03 | 262 | 51 | 4 | 362 | |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP | 1.17e-05 | 198 | 67 | 6 | M3200 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 1.28e-05 | 201 | 67 | 6 | MM1006 | |
| CoexpressionAtlas | Myeloid Cells, MF.Sbcaps.SLN, CD11b+ CD169+ F4/80-, Lymph Node, avg-2 | 1.39e-06 | 61 | 67 | 5 | GSM854324_100 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.16e-07 | 167 | 68 | 6 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-23|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-06 | 144 | 68 | 5 | e9d62f202f0fa8747961036ef0eafed91fe8a42f | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-06 | 161 | 68 | 5 | b9a17f41426bf715f30bf544a6795afaf37a3aa6 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-06 | 161 | 68 | 5 | f7a89c481f789f624102857be722c95fbeb47595 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.07e-06 | 169 | 68 | 5 | e36b8cd0230bbb761df7606129ebfd77111af10b | |
| ToppCell | metastatic_Brain-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 6.61e-06 | 172 | 68 | 5 | 38d17e769fe8eac8b57b820490d4ddd969243ee7 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.99e-06 | 174 | 68 | 5 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.19e-06 | 175 | 68 | 5 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.39e-06 | 176 | 68 | 5 | 0f55de48bbc396c187f2a7d1d7da20862c715f9e | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.81e-06 | 178 | 68 | 5 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.46e-06 | 181 | 68 | 5 | f737f2b1f35747b81fdd8996e289bde5c290af61 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.46e-06 | 181 | 68 | 5 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.93e-06 | 183 | 68 | 5 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.93e-06 | 183 | 68 | 5 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 9.91e-06 | 187 | 68 | 5 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.15e-05 | 193 | 68 | 5 | 52f42ec293a5077a44de5c27e89b57c23944e560 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 1.21e-05 | 195 | 68 | 5 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | BAL-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-05 | 197 | 68 | 5 | 513ada82bbbb6a624d89edaa54f8c4a303dfb5e7 | |
| ToppCell | Control-Myeloid-cDC|Control / Disease group,lineage and cell class （2021.01.30） | 1.27e-05 | 197 | 68 | 5 | aef933107da42a763b35041c90950db07707c0cb | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-05 | 197 | 68 | 5 | 15e683f4a610aad3e06723747c8e56ca25f57414 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.31e-05 | 198 | 68 | 5 | 898be90c906ebc806a764ae6c21bbf84649b6b30 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Dendritic_cell-DC_2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 200 | 68 | 5 | f0e7c2f07a7065511bf0b6521ce2e74e04e48544 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.29e-05 | 127 | 68 | 4 | 9bc55cb9f4bddb274930784d12a83b9dceb35cb7 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.80e-05 | 143 | 68 | 4 | 5a279da1cd8e63db32f7c85a73b493c2121d0a96 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-05 | 143 | 68 | 4 | 990844ca674d30b2924c74b45bed4fdfb8463fa7 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.18e-05 | 145 | 68 | 4 | 997bd540c43725a85ca97e4b79ebe0d336860287 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.37e-05 | 146 | 68 | 4 | 03a6a442f1f6d173a41aeebbfe41ee08853d9585 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.30e-05 | 155 | 68 | 4 | 62b59cb32b12bd55b19e98786a866d788fc9e4bf | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.30e-05 | 155 | 68 | 4 | 15bacd06cc2b02b13c85bb71c5b758e5ff613e80 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 157 | 68 | 4 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 157 | 68 | 4 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 158 | 68 | 4 | 12661763d1c309106801cb710c04cd2b62d16cba | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 158 | 68 | 4 | e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 158 | 68 | 4 | 0792c39e6fc0745095af7812de2d50949540d60f | |
| ToppCell | TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue-5|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.00e-04 | 158 | 68 | 4 | 34b284a62cc3fb90429ce579fd8cb8a60178091b | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 159 | 68 | 4 | 5c7a099aa84ecc62bf9b5e1609e5b6b77889f175 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.08e-04 | 161 | 68 | 4 | 1670108afc0af90861eb80a84e59995571c0da1b | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.08e-04 | 161 | 68 | 4 | 1d446f5ba57d84949823a35cbedaee8f448fe40f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-04 | 163 | 68 | 4 | e4077e587895c85bc806be05ff5d451088e39468 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 163 | 68 | 4 | 476e94e1d132eaaecb9e376bd32748a75ad22081 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 165 | 68 | 4 | 004d793bf5bb6fb3b7bf38baf11b32d46375fe4d | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-04 | 166 | 68 | 4 | de319c960b0cd90b294f677d1ea1b013a2ce2d53 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 167 | 68 | 4 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 169 | 68 | 4 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.36e-04 | 171 | 68 | 4 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.36e-04 | 171 | 68 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | Healthy/Control-MAIT|World / Disease group and Cell class | 1.36e-04 | 171 | 68 | 4 | 61515114b17816a8f9ef6a57262eb9e977b6ede4 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.42e-04 | 173 | 68 | 4 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell-basophil_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 173 | 68 | 4 | 120dd20e8a71f9169a1596b6171df7aa0b96dd15 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-Basophil/Mast_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.42e-04 | 173 | 68 | 4 | b2c55084ef6dac0e329c2e65c24cfe0045859c30 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-MAIT|lymph-node_spleen / Manually curated celltypes from each tissue | 1.52e-04 | 176 | 68 | 4 | 25c197d3b39deffa4801a1d12cdb54320cbae509 | |
| ToppCell | Healthy-RBC|World / disease group, cell group and cell class | 1.55e-04 | 177 | 68 | 4 | 2ce41e37fa7139c7bd2b464bd86c5601dc501515 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 177 | 68 | 4 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | Healthy-RBC|Healthy / disease group, cell group and cell class | 1.55e-04 | 177 | 68 | 4 | 945d72ab52efa9a9468daace9f9ec676a891d963 | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / Disease condition and Cell class | 1.55e-04 | 177 | 68 | 4 | 8eb69041f482b58325e3539f607923f7b1fa5977 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 181 | 68 | 4 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 181 | 68 | 4 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.69e-04 | 181 | 68 | 4 | 3457c1d431db4282be5a6243119e48960748ede7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 183 | 68 | 4 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.76e-04 | 183 | 68 | 4 | 24679153b654c148dbd572e9013c0a6e58718ada | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 1.80e-04 | 184 | 68 | 4 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | PCW_10-12-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.80e-04 | 184 | 68 | 4 | 33db879e629821fb75684e60f8f0749cf9623bdd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 184 | 68 | 4 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-04 | 185 | 68 | 4 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-MAIT_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-04 | 185 | 68 | 4 | 8314dc608bc837df3037e89afd9db39737374ebc | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.87e-04 | 186 | 68 | 4 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 187 | 68 | 4 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.95e-04 | 188 | 68 | 4 | 3f47395db7e6159fc95810545bad4b6e028464c5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 188 | 68 | 4 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 188 | 68 | 4 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-04 | 189 | 68 | 4 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | (3)_Chondrocytes-(31)_Chondro-hyper|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.99e-04 | 189 | 68 | 4 | 394b153393904c3dba51a6bfe338afd554e66649 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-04 | 189 | 68 | 4 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.99e-04 | 189 | 68 | 4 | 7899af78b273d9c7f029d52f7e0cf6df4da41f5e | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-04 | 189 | 68 | 4 | 723c57f278919e8251d56b3d19411f9088319450 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-04 | 189 | 68 | 4 | 960374f5fb278659500a7c948c3068a95dd62eb0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-04 | 190 | 68 | 4 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 190 | 68 | 4 | 0bad41d19dc515e6bc61e699f4d56664cf2e72fd | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC2|Lung / Manually curated celltypes from each tissue | 2.03e-04 | 190 | 68 | 4 | 468525c05e38158a3b8a445882b2d63dfb1d2c63 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 2.03e-04 | 190 | 68 | 4 | 58a6ab70737d719ca9725ac087f20dfe9be0463e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.07e-04 | 191 | 68 | 4 | 98b907f8fa024cf32e462323b782c5a371327bbd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 191 | 68 | 4 | 5717809a1476c20f65bce722c5a57cff92ee0d7a | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 2.11e-04 | 192 | 68 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.11e-04 | 192 | 68 | 4 | 892789bdba150ef9a8a0012de52545f2ff6a31f6 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-MAIT|COVID-19_Mild / Disease group, lineage and cell class | 2.11e-04 | 192 | 68 | 4 | d47bd132e57f5b4bddcf3dfa399cee149eca7e44 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.11e-04 | 192 | 68 | 4 | 24ea8fdcca2695aeb2e4b88161184124b7d332c1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.11e-04 | 192 | 68 | 4 | 44f440ee3842fe14665c4cd4f2aa48e7a5bbd9a8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.11e-04 | 192 | 68 | 4 | 8d50ad8cfe3cb9f183188b08457756af0ce56ffe | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_neutrophils_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.16e-04 | 193 | 68 | 4 | c9e3fefa8d68d0e2b954f85ce37813185ff98d84 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.16e-04 | 193 | 68 | 4 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.16e-04 | 193 | 68 | 4 | 9a6c5b7c8e88cf7a261f8e052df1709d2c0a91f0 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.20e-04 | 194 | 68 | 4 | 920955e775617d6156c5ee8b90d2cecd01a70e12 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.20e-04 | 194 | 68 | 4 | 85c5d07189eb7bb413f708a3ca40de08af3cb106 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.20e-04 | 194 | 68 | 4 | e56c6e5c9b7d287ae94566b561e21cec2055f83d | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm/em_CD8|bone_marrow / Manually curated celltypes from each tissue | 2.24e-04 | 195 | 68 | 4 | ed4e2275dac47cc9fb9c381e3f80fed0ce50b074 | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.24e-04 | 195 | 68 | 4 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 2.24e-04 | 195 | 68 | 4 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.24e-04 | 195 | 68 | 4 | 85fee07d71c0393ea42bcf1130566dff4a62f507 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 195 | 68 | 4 | 5f46f9aca1c7f76416e861aa94d24fc1d6266113 | |
| Computational | Genes in the cancer module 146. | 2.16e-06 | 102 | 41 | 6 | MODULE_146 | |
| Computational | Genes in the cancer module 288. | 1.10e-05 | 37 | 41 | 4 | MODULE_288 | |
| Computational | Genes in the cancer module 289. | 1.01e-04 | 124 | 41 | 5 | MODULE_289 | |
| Computational | GPCR signaling pathways (immune and neuro). | 3.67e-04 | 90 | 41 | 4 | MODULE_375 | |
| Disease | Bipolar Disorder | 8.76e-07 | 477 | 64 | 9 | C0005586 | |
| Disease | CCL2 measurement | 8.17e-06 | 126 | 64 | 5 | EFO_0004749 | |
| Disease | mucolipidosis type IV (implicated_via_orthology) | 1.39e-05 | 3 | 64 | 2 | DOID:0080490 (implicated_via_orthology) | |
| Disease | periapical granuloma (is_marker_for) | 1.39e-05 | 3 | 64 | 2 | DOID:4617 (is_marker_for) | |
| Disease | Rickets | 2.77e-05 | 4 | 64 | 2 | C0035579 | |
| Disease | glycoproteinosis (implicated_via_orthology) | 2.77e-05 | 4 | 64 | 2 | DOID:3343 (implicated_via_orthology) | |
| Disease | rhinitis (is_implicated_in) | 3.79e-05 | 30 | 64 | 3 | DOID:4483 (is_implicated_in) | |
| Disease | visual epilepsy (biomarker_via_orthology) | 4.47e-05 | 90 | 64 | 4 | DOID:11832 (biomarker_via_orthology) | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 4.61e-05 | 5 | 64 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | plasma plasminogen measurement | 4.61e-05 | 5 | 64 | 2 | EFO_0006309 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 6.49e-05 | 99 | 64 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | triglyceride measurement, alcohol drinking | 6.49e-05 | 99 | 64 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | angiostatin measurement | 6.91e-05 | 6 | 64 | 2 | EFO_0008024 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 7.02e-05 | 101 | 64 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 7.29e-05 | 102 | 64 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 9.66e-05 | 7 | 64 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 1.13e-04 | 43 | 64 | 3 | EFO_0022290 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 1.77e-04 | 50 | 64 | 3 | EFO_0022303 | |
| Disease | aminoadipic acid measurement | 1.77e-04 | 50 | 64 | 3 | EFO_0010459 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.88e-04 | 51 | 64 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.88e-04 | 51 | 64 | 3 | EFO_0022240 | |
| Disease | polyunsaturated fatty acid measurement | 1.92e-04 | 131 | 64 | 4 | EFO_0010733 | |
| Disease | triglycerides in HDL measurement | 2.11e-04 | 53 | 64 | 3 | EFO_0022317 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.11e-04 | 53 | 64 | 3 | EFO_0022286 | |
| Disease | macrophage inflammatory protein 1b measurement | 2.21e-04 | 136 | 64 | 4 | EFO_0008219 | |
| Disease | triglycerides in medium HDL measurement | 2.23e-04 | 54 | 64 | 3 | EFO_0022321 | |
| Disease | triglycerides in LDL measurement | 2.49e-04 | 56 | 64 | 3 | EFO_0022320 | |
| Disease | triglycerides to total lipids in small LDL percentage | 2.90e-04 | 59 | 64 | 3 | EFO_0022337 | |
| Disease | triglycerides in medium LDL measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0022322 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 3.52e-04 | 63 | 64 | 3 | EFO_0022283 | |
| Disease | Asthma, Aspirin-Induced | 3.56e-04 | 13 | 64 | 2 | C1319853 | |
| Disease | triglycerides in small LDL measurement | 3.86e-04 | 65 | 64 | 3 | EFO_0022323 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 4.60e-04 | 69 | 64 | 3 | EFO_0022341 | |
| Disease | rheumatoid arthritis (is_marker_for) | 4.60e-04 | 69 | 64 | 3 | DOID:7148 (is_marker_for) | |
| Disease | Nonorganic psychosis | 4.60e-04 | 69 | 64 | 3 | C0349204 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 5.45e-04 | 16 | 64 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 5.65e-04 | 74 | 64 | 3 | EFO_0022280 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 5.88e-04 | 75 | 64 | 3 | EFO_0022287 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 6.59e-04 | 78 | 64 | 3 | EFO_0022187 | |
| Disease | colorectal cancer, inflammatory bowel disease | 7.73e-04 | 19 | 64 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | COVID-19, osteoarthritis | 8.58e-04 | 20 | 64 | 2 | MONDO_0005178, MONDO_0100096 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 8.95e-04 | 197 | 64 | 4 | EFO_0005680 | |
| Disease | Deep Vein Thrombosis | 9.47e-04 | 21 | 64 | 2 | C0149871 | |
| Disease | Venous Thrombosis | 9.47e-04 | 21 | 64 | 2 | C0042487 | |
| Disease | myocardial infarction | 9.81e-04 | 350 | 64 | 5 | EFO_0000612 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.03e-03 | 91 | 64 | 3 | EFO_0004611, EFO_0005271 | |
| Disease | Neurodevelopmental Disorders | 1.10e-03 | 93 | 64 | 3 | C1535926 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.17e-03 | 95 | 64 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.20e-03 | 96 | 64 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.24e-03 | 215 | 64 | 4 | EFO_0008317, EFO_0008591 | |
| Disease | vasculitis | 1.24e-03 | 24 | 64 | 2 | EFO_0006803 | |
| Disease | total cholesterol measurement, intermediate density lipoprotein measurement | 1.32e-03 | 99 | 64 | 3 | EFO_0004574, EFO_0008595 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.35e-03 | 220 | 64 | 4 | EFO_0004529, EFO_0008317 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.39e-03 | 222 | 64 | 4 | EFO_0008317, EFO_0020943 | |
| Disease | Psychotic Disorders | 1.39e-03 | 101 | 64 | 3 | C0033975 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.44e-03 | 224 | 64 | 4 | EFO_0004574, EFO_0008317 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.46e-03 | 225 | 64 | 4 | EFO_0008317, EFO_0010351 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.46e-03 | 225 | 64 | 4 | EFO_0008317, EFO_0020947 | |
| Disease | free cholesterol measurement, intermediate density lipoprotein measurement | 1.52e-03 | 104 | 64 | 3 | EFO_0008591, EFO_0008595 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.56e-03 | 229 | 64 | 4 | EFO_0004639, EFO_0008317 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.60e-03 | 106 | 64 | 3 | EFO_0008317, EFO_0008596 | |
| Disease | Oral ulcer | 1.64e-03 | 107 | 64 | 3 | HP_0000155 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.73e-03 | 109 | 64 | 3 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.78e-03 | 110 | 64 | 3 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.78e-03 | 110 | 64 | 3 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.78e-03 | 110 | 64 | 3 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.82e-03 | 239 | 64 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | large artery stroke | 1.92e-03 | 113 | 64 | 3 | EFO_0005524 | |
| Disease | glycocholate measurement | 1.94e-03 | 30 | 64 | 2 | EFO_0010491 | |
| Disease | monocyte count | 2.10e-03 | 1320 | 64 | 9 | EFO_0005091 | |
| Disease | Cocaine-Related Disorders | 2.12e-03 | 117 | 64 | 3 | C0236736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLVTSVVWAIGEYLS | 641 | O43299 | |
| LIWSNSVRFVIDVGV | 346 | Q7L7V1 | |
| WSVLEGFRVTLTSVI | 11 | Q9H257 | |
| VQGGRTVTTVKFWFA | 186 | Q9Y644 | |
| GTSTLLVWVGVIRYL | 391 | Q9GZU1 | |
| WLASFGTVRTVYVAA | 76 | O15528 | |
| VVWLVTFTDIGLTAR | 221 | Q6ZVH7 | |
| GSVVSGAVVAAVIWR | 316 | P13747 | |
| SWTVRAVVQVRTIVG | 231 | O95256 | |
| FVTSGVWNVTELVRV | 216 | Q14938 | |
| IIGVAAGRFHTVLWT | 286 | Q9P2D0 | |
| FASVLTTIGNWLRVV | 246 | Q9NYG8 | |
| VVFGLEYIVRVWSAG | 141 | P56696 | |
| WRYGVSITLSGRTAT | 356 | P54315 | |
| VLLVVSWVGGFLHSV | 141 | Q6IF82 | |
| TAIISYGTTGLVTWD | 126 | Q96G04 | |
| YVAVSWGVVVAVTGT | 21 | Q9NQS5 | |
| VTGEEWLVTTVGAYL | 191 | Q14764 | |
| WVFVTLRVITAAVTV | 6 | P16112 | |
| YVGIAVIWVLAVASS | 156 | P25929 | |
| GWLRGSITLFAVITV | 131 | Q7RTM1 | |
| ITGIGWLYDVTSSIT | 1166 | A4FU69 | |
| TVTFGVITSIVTWGL | 146 | P51677 | |
| AWGNGRVSVTRVITV | 3701 | Q9Y6R7 | |
| SGRVLAFIFVASVIW | 11 | Q7Z7M9 | |
| FVTSFVGWIGVIVTT | 11 | O75508 | |
| IISSVRSGSRYIITW | 911 | Q12860 | |
| GVYARVSRFVTWIEG | 2021 | P08519 | |
| ARTVTFGVVTSVITW | 151 | P41597 | |
| FGVVTSVITWLVAVF | 156 | P41597 | |
| SVVVRDTAAWTVGRI | 421 | Q14974 | |
| RTWILTVGYTTAFGA | 556 | O75899 | |
| SVTITWTRVPGATGY | 701 | Q02388 | |
| VLRITWVGVTGATAY | 791 | Q02388 | |
| GSVVAVGTLTGRWFV | 596 | O00423 | |
| TVVAIGTHSGRWFVL | 646 | Q9HC35 | |
| ALVGAWYTARKSITV | 26 | Q3SXM5 | |
| GWVYDRSVFTSTIVA | 116 | Q9NSA0 | |
| GVILFLRLTWVVGTA | 201 | Q9UHW9 | |
| FLGTSTLLVWVGVIR | 381 | Q8IZK6 | |
| VVYLEVTGGVWNFSR | 86 | P35462 | |
| LWVTFAIGSVIVGVT | 826 | Q3KNS1 | |
| LGKSWAFLVGVVVTV | 266 | Q9H756 | |
| WGRIVTLISFGAFVA | 261 | Q07820 | |
| QYSVWVVAVTSAGRG | 1256 | O60469 | |
| TSALARGVSGIFVWT | 51 | Q6ZMB5 | |
| RGVSGIFVWTALVLT | 56 | Q6ZMB5 | |
| TGLFWVTGLITVIVS | 516 | P53794 | |
| VFVIAVGIWSSIRAS | 46 | Q2M3M2 | |
| ALWSLAYGVVVAVAV | 86 | P29371 | |
| GVYVRVSRFVTWIEG | 791 | P00747 | |
| GWEVRSTVSGRIYFV | 311 | Q9HCE7 | |
| RTVVVLTVIWTFCTG | 146 | Q01718 | |
| RFVCVGIWIFVILTS | 141 | Q9Y271 | |
| IVGVAAYVGWQSSSI | 601 | Q99570 | |
| VIVTGHSDGVVRFWR | 3231 | Q8IZQ1 | |
| VVTGGYLISSWATSI | 96 | O15374 | |
| LPAVFVAVWVSVRAT | 331 | Q03431 | |
| LITIGVATWGTVHRR | 236 | O94759 | |
| TARLVGVLWFVSVTT | 16 | Q9BX74 | |
| VWRITVSEGFHVGLT | 491 | Q9Y6L7 | |
| AAPFRTFWVVSVVLG | 896 | Q4G0T1 | |
| EVSYIGITSSGVVWE | 3106 | Q709C8 | |
| RSLSATVVVYVNGGW | 241 | Q6UXZ4 | |
| AVFWVLGATLVVIGS | 151 | Q9UI14 | |
| VRVSLDYEVGWVTFT | 431 | Q9UDY6 | |
| LFWLVLVVVFVTGAT | 1166 | Q92508 | |
| FRVVTWAVFVGLSLA | 41 | P0C7U3 | |
| TTATVIVYVNGGWST | 251 | O95185 | |
| TFSAWYVDGRVLVVI | 186 | Q9H2H9 | |
| WSVGVLTYVLLSGVS | 2976 | O75962 |